TAKEDA DEVELOPMENT CENTRE EUROPE LTD.
Get an alert when TAKEDA DEVELOPMENT CENTRE EUROPE LTD. files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-12-31 (in 7mo)
Last filed for 2025-03-31
Confirmation statement due
2026-10-05 (in 5mo)
Last made up 2025-09-21
Watchouts
Cash
£269K
+4% vs 2024
Net assets
£107K
-2.4% vs 2024
Employees
—
Average over period
Profit before tax
£0
-100% vs 2024
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
The directors continue to take the decision to prepare the financial statements on a non-going concern basis because the Directors plan to wind up the company in conjunction with the Takeda project for integration and rationalisation of legal entities. These plans are in progress and are approaching completion, as remaining commitments are reviewed and concluded.
Name history
Renamed 3 times since incorporation
- TAKEDA DEVELOPMENT CENTRE EUROPE LTD. 2013-06-26 → present
- TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE (EUROPE) LTD 2006-03-15 → 2013-06-26
- TAKEDA EUROPE RESEARCH AND DEVELOPMENT CENTRE LTD 1999-01-29 → 2006-03-15
- TAKEDA EUROPE R & D CENTRE LTD. 1998-09-21 → 1999-01-29
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2025-03-31
| Metric | Trend | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Turnover | £295,893 | £12,465 | |
| Operating profit | £117,000 | £0 | |
| Profit before tax | £117,000 | £0 | |
| Net profit | £87,165 | -£2,579 | |
| Cash | £258,253 | £268,655 | |
| Total assets less current liabilities | £109,649 | £107,070 | |
| Net assets | £109,649 | £107,070 | |
| Equity | £109,649 | £107,070 | |
| Average employees | — | — | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating margin | 39.5% | 0.0% | |
| Net margin | 29.5% | -20.7% | |
| Return on capital employed | 106.7% | 0.0% | |
| Current ratio | 1.43x | 1.60x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“The directors continue to take the decision to prepare the financial statements on a non-going concern basis because the Directors plan to wind up the company in conjunction with the Takeda project for integration and rationalisation of legal entities. These plans are in progress and are approaching completion, as remaining commitments are reviewed and concluded.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 29 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| DRISCOLL, Bryan Joseph | Secretary | 2006-12-21 | — | British |
| MEMIS, Seyda Atadan | Director | 2025-08-31 | Mar 1979 | Turkish |
| MIURA, Itaru | Director | 2025-11-04 | Nov 1975 | Japanese |
| PAGE, Marc Stuart | Director | 2021-05-10 | Feb 1985 | British |
Show 29 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| MOULES, Ian Keith | Secretary | 2005-09-30 | 2006-12-21 |
| OZAWA, Tatsuharu | Secretary | 1999-06-30 | 2001-06-20 |
| TANAKA, Shingo | Secretary | 2001-06-20 | 2003-05-28 |
| UMINO, Daisuke | Secretary | 2003-05-28 | 2005-09-30 |
| YUKI, Hideaki | Secretary | 1998-09-21 | 1999-06-30 |
| BREEN, Sean Anthony | Director | 2014-10-03 | 2015-09-22 |
| CARLSON, James Edward | Director | 2019-03-25 | 2020-11-20 |
| CHEYNE, Sian | Director | 2011-10-01 | 2021-03-16 |
| COLES, Stephen John, Dr | Director | 2009-11-16 | 2011-03-31 |
| DAISUKE, Umino | Director | 2004-04-01 | 2005-04-01 |
| DOLLOW, Stuart Clive, Dr | Director | 2011-04-01 | 2014-09-17 |
| ECKLAND, David John Augustus, Dr | Director | 2002-06-30 | 2005-04-29 |
| EIJGENHUIJSEN, Rosalyn Joan | Director | 2017-01-13 | 2019-03-12 |
| GEORGE, Michael John, Dr | Director | 2005-05-01 | 2009-11-16 |
| GRUBIN, Peter Michael | Director | 2022-08-30 | 2025-08-31 |
| HIGUCHI, Shuji | Director | 1998-09-21 | 2002-06-30 |
| ISAACS, David | Director | 2010-02-10 | 2021-06-30 |
| IWATSUKA, Shin | Director | 2006-04-01 | 2007-04-01 |
| MIYAZAKI, Masahiro | Director | 2007-04-01 | 2010-02-09 |
| MORIMOTO, Kenjiro | Director | 2003-06-30 | 2013-08-29 |
| OGAWA, Atsushi | Director | 2015-09-23 | 2017-01-12 |
| REID, Charmaine Linda | Director | 2020-11-17 | 2022-08-31 |
| ROSS, Geoffrey George, Dr | Director | 2014-10-31 | 2018-07-31 |
| SUGIE, Yasuharu | Director | 1998-09-21 | 2003-06-30 |
| WADA, Yashuhiko | Director | 2005-04-01 | 2006-04-01 |
| WADA, Yasuhiko | Director | 2002-06-30 | 2004-04-01 |
| WRIGHT, Padraig, Dr | Director | 2013-10-21 | 2014-10-22 |
| YAMADA, Takeshi | Director | 2010-02-10 | 2011-09-30 |
| YUKI, Hideaki | Director | 1998-09-21 | 1998-09-21 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Takeda Pharmaceutical Company Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 138 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-01-04 | AA | accounts | Accounts with accounts type full | |
| 2025-11-07 | AP01 | officers | Appoint person director company with name date | |
| 2025-09-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-09-08 | AP01 | officers | Appoint person director company with name date | |
| 2025-09-05 | TM01 | officers | Termination director company with name termination date | |
| 2025-07-11 | CH01 | officers | Change person director company with change date | |
| 2024-12-31 | AA | accounts | Accounts with accounts type full | |
| 2024-09-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-05-13 | AA | accounts | Accounts with accounts type full | |
| 2024-05-03 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2023-09-29 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-04-08 | AA | accounts | Accounts with accounts type full | |
| 2022-09-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-12 | TM01 | officers | Termination director company with name termination date | |
| 2022-09-12 | AP01 | officers | Appoint person director company with name date | |
| 2022-03-31 | AA | accounts | Accounts with accounts type full | |
| 2021-09-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-07-01 | TM01 | officers | Termination director company with name termination date | |
| 2021-05-10 | AP01 | officers | Appoint person director company with name date | |
| 2021-03-24 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 0
- Officers appointed
- 2
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-03-31 vs 2024-03-31
-
Turnover
-95.8%
£295,893 £12,465
-
Cash
+4%
£258,253 £268,655
-
Net assets
-2.4%
£109,649 £107,070
-
Employees
—
Not reported
-
Operating profit
-100%
£117,000 £0
-
Profit before tax
-100%
£117,000 £0
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers